More importantly, IFN‐β treatment in a multiple sclerosis patient completely reversed subfoveal neovascularization and choroiditis emphasizing the therapeutic potential of IFN‐β for inflammatory and vascular diseases of the eye (Cirino et al,2006). The gene discussed is IFNB1; the disease is eye adnexa disorder.